News on Projects | India - Drugs & Pharma - New projects information in India, Middle East, South Asia

Ahmedabad-based Cadila Pharmaceuticals will invest ₹100 crore to set up a pharmaceuticals formulations manufacturing facility at Malipada near Bhubaneswar in Odisha. According to the company, it has signed an investment intention... Full Story

Aurobindo Pharma aims to complete Rs. 2000 Cr Pen-G plant in Andhra Pradesh by March'24.

Aurobindo Pharma's aims to complete its Rs. 2,000 crore Penicillin G (Pen G) plant in Andhra Pradesh by March 2024 even as... Full Story

Browse All News by Date

Biological E to invest ₹1,800 crore in Hyderabad to expand vaccine manufacturing capacity.

Biological E will invest over ₹1,800 crore for expanding manufacturing capacity of vaccines along with generic Injectables and Research and Development... Full Story

More General Stories

LATEST HEADLINES FROM MIDDLE EAST AND NORTH AFRICA

Solara receives EDQM CEP approval for its API unit in Vishakhapatnam.
Solara Active Pharma Sciences announced that its new state of the art multipurpose API manufacturing facility at Vishakhapatnam, Andhra Pradesh, had received 'Certificate of Suitability'... Full Story
IIL to set up new animal vaccine unit in Hyderabad at ₹700 cr.
Indian Immunologicals Limited (IIL) will invest about ₹700 crore in setting up a new animal vaccine manufacturing facility in Genome Valley, Hyderabad. The new plant... Full Story
Lincoln Pharmaceuticals acquires Cephalosporin plant in Mehsana.
Lincoln Pharmaceuticals Limited recently announced the acquisition of a Cephalosporin manufacturing plant in Mehsana. Lincoln will launch Cephalosporin products - antibiotics - soon, it said. The company plans to... Full Story
Torrent acquires Elder unit for Rs. 2,000 crore.
Ahmedabad-based Torrent is set to acquire Mumbai-based Elder Pharma's entire domestic formulations business in India and Nepal for Rs. 2,004 crore, making it the first... Full Story
Intas Pharma is planning to raise R2. 50Cr PE investment for expansion
Intas Pharma is planning to raise R250Cr private equity investment for expansion. Intas Pharma filed DRHP to raise upto R425Cr through fresh issue of shares. The company... Full Story
Ranbaxy gets approval for drugs treating seizures
New Delhi: Ranbaxy Laboratories has received approval from the US Food and Drug Administration (USFDA) to market and manufacture a generic drug for treating seizures.... Full Story
Novartis to increase its stake in Indian subsidiary
Mumbai: The Swiss company Novartis is set to increase stake in its Indian subsidiary to nearly 90 per cent from the existing 51 per cent.... Full Story
Ind-Swift expects sales of Rs 1,200 cr
Chandigarh: Ind-Swift group, a Chandigarh-based research-driven pharmaceutical group with presence across 45 countries, expects to close the current fiscal with collective sales of Rs 1,200... Full Story